These mice are generated by transplanting human hepatocytes into albumin enhancer–driven urokinase-type plasminogen activator transgenic/severe combined immunodeficiency (uPA/SCID) mice, leading to replacement of the host hepatocytes at a repopulation rate exceeding 70% [27, 28]. This evidence concerns the gene PLAU and severe combined immunodeficiency.